![](/img/cover-not-exists.png)
Heritage, a phase III safety and efficacy trial of the proposed trastuzumab biosimilar, Myl-1401O vs trastuzumab
Rugo, H., Barve, A., Waller, C.F., Bronchud, M., Herson, J., Yuan, J., Manikhas, A., Bondarenko, I., Mukhametshina, G., Nemsadze, G., Parra, J.D., Abesamis-Tiambeng, M.L.T., Baramidze, K., Akewanlop,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw435.06
Date:
October, 2016
File:
PDF, 41 KB
english, 2016